These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 15863546

  • 1. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [Abstract] [Full Text] [Related]

  • 2. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 3. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC, Felson DT, Williams EN, Grady D.
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [Abstract] [Full Text] [Related]

  • 4. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators.
    N Engl J Med; 2003 Aug 07; 349(6):523-34. PubMed ID: 12904517
    [Abstract] [Full Text] [Related]

  • 5. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 6. Estrogen plus progestin and colorectal cancer in postmenopausal women.
    Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, Women's Health Initiative Investigators.
    N Engl J Med; 2004 Mar 04; 350(10):991-1004. PubMed ID: 14999111
    [Abstract] [Full Text] [Related]

  • 7. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec 04; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 8. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP.
    Am J Obstet Gynecol; 2003 Jan 04; 188(1):92-9. PubMed ID: 12548201
    [Abstract] [Full Text] [Related]

  • 9. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
    Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM, Women's Health Initiative Investigators.
    Circulation; 2004 Feb 10; 109(5):620-6. PubMed ID: 14769684
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD, Durand-Carbajal M, Jiménez-Santana L, Lara-Reyes P, Seuc AH, Sánchez-Guerrero J.
    Arthritis Care Res (Hoboken); 2011 Dec 10; 63(12):1654-63. PubMed ID: 22127965
    [Abstract] [Full Text] [Related]

  • 11. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.
    Am J Obstet Gynecol; 2001 Nov 10; 185(5):1180-5. PubMed ID: 11717654
    [Abstract] [Full Text] [Related]

  • 12. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 13. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V, van der Mooren MJ, Kenemans P, de Valk-de Roo GW, Netelenbos C.
    Menopause; 1999 Sep 20; 6(2):134-7. PubMed ID: 10374220
    [Abstract] [Full Text] [Related]

  • 14. Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.
    Davies GC, Huster WJ, Shen W, Mitlak B, Plouffe L, Shah A, Cohen FJ.
    Menopause; 1999 Sep 20; 6(3):188-95. PubMed ID: 10486787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N.
    Clin Pharmacol Ther; 1998 Aug 20; 64(2):204-10. PubMed ID: 9728901
    [Abstract] [Full Text] [Related]

  • 17. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
    Gast MJ, Freedman MA, Vieweg AJ, De Melo NR, Girão MJ, Zinaman MJ, Dyspareunia Study Group.
    Menopause; 2009 Aug 20; 16(2):247-56. PubMed ID: 19034054
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial.
    Brunner RL, Gass M, Aragaki A, Hays J, Granek I, Woods N, Mason E, Brzyski R, Ockene J, Assaf A, LaCroix A, Matthews K, Wallace R, Women's Health Initiative Investigators.
    Arch Intern Med; 2005 Sep 26; 165(17):1976-86. PubMed ID: 16186467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.